Redeye Investor Forum Online
VirtualCEO Ellen Donnelly will present the company at 1:20 p.m. CEST.
Delivering mitochondrial health
CEO Ellen Donnelly will present the company at 1:20 p.m. CEST.
The US patient organization United Mitochondrial Disease Foundation (UMDF) is hosting its annual Mitochondrial Medicine Symposium, this year virtual, in June. Abliva will participate in the scientific sessions: Chief Medical […]
Abliva will participate at Aktiespararna's Kvinnokvällen (Women's night) in Gothenburg, on 31 August 2021. CEO Ellen Donnelly will be presenting the company digitally, at 6 p.m. CEST. Follow the event […]
Now you can sign up for LHON Eye Society's 5 km Mito-race, either in Stockholm on 15 September, or the virtual one on 12 - 18 September. The event takes […]
Every year, during the third week of September, the World Mitochondrial Disease Week (WMDW) is being held. This global, important, and rapidly growing event was an initiative from patient organization […]
Abliva would like to invite interested shareholders and investors to a fun and informal “Fireside Chat” with the company's CEO, Ellen Donnelly, and members of the Abliva team, in Stockholm […]
Abliva will attend the digital/hybrid event: 21st Annual Biotech in Europe Forum (BEF), on 7 - 8 October 2021.
Italian patient organization Mitocon arranges this year's Mitochondrial Diseases Conference in virtual. Abliva's Chief Medical Officer, Magnus Hansson, will give a flash presentation and join round table discussions at the […]
Abliva will attend Aktiespararna's Kvinnokvällen Malmö, on 19 October 2021.. CEO Ellen Donnelly will be presenting the company at 7:30 p.m. CEST.
Abliva will attend the BioStock Life Science Summit 2021. CEO Ellen Donnelly will be presenting the company on 20 October at 2:00 p.m. CEST.
Abliva will attend the virtual conference Mitochondrial Medicine - Therapeutic Development, organized by the Wellcome Connecting Science located at the Wellcome Genome Campus in the UK, on 30 Nov - 2 […]
Abliva will attend and present at the Mitochondria-Targeted Drug Development Summit in Boston, MA, USA. The event will be held on 22 - 24 February 2022. CEO Ellen Donnelly will […]